Cantor Fitzgerald Downgrades DICE Therapeutics (DICE) to Neutral following takeover Jun 20, 2023 11:52AM
DICE Therapeutics (DICE) PT Raised to $68 at Cantor Fitzgerald Oct 11, 2022 11:30AM